This reduction in nitric oxide (NO) availability is attributed to multiple factors, including a decrease in insulin-mediated NO synthesis and an increase in reactive oxygen species (ROS) generated during insulin resistance, which accelerates NO degradation. This evidence concerns the gene INS and Insulin resistance.